US board voids Halozyme patent, boosting MSD and Koreas Alteogen PTABs first PGR win for MSD undermines Halozyme and ...
Erasca (ERAS) on Monday announced a clinical trial collaboration and supply agreement (CTCSA) with Merck (MRK), known as MSD ...
(Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers, today ...
MSD (Merck) will acquire Terns Pharmaceuticals for approximately USD 6.7 billion, adding investigational leukemia therapy ...
The Chosun Ilbo on MSN
Eli Lilly's Mounjaro surpasses Merck's Keytruda as best-selling drug
Eli Lilly and Company’s obesity and diabetes treatment ‘Mounjaro’ has surpassed MSD (Merck & Co., Inc.)’s cancer drug ...
RAHWAY, N.J. & SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, and Harpoon Therapeutics, Inc. (Nasdaq: HARP) today announced that ...
Merck highlights new long-term data and advancements across broad oncology portfolio and pipeline research at ASCO 2026: Rahway, New Jersey Wednesday, May 13, 2026, 11:00 Hrs [IST ...
Addition of TERN-701, a novel investigational oral allosteric BCR::ABL1 tyrosine kinase inhibitor, further diversifies Merck’s oncology pipelineRAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known ...
CAMBRIDGE, England--(BUSINESS WIRE)--Microbiotica, a leader in discovering and developing microbiome-based therapeutics and biomarkers, today announces it has entered into a clinical trial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results